Clopidogrel (Clopicard 75mg) is an anti-platelet agent, that is, a drug that inhibits the ability of platelets to clump together as part of a blood clot. Clopidogrel (Clopicard 75mg) is prescribed ...

Teva Pharmaceuticals has announced theintroduction and availability of Clopidogrel Tablets, an AB rated andbioequivalent product to Plavix Tablets (Bristol-Myers Squibb and SanofiAventis). Clopidogrel ...

Clopidogrel (Noklot (300 mg)) is an anti-platelet agent, that is, a drug that inhibits the ability of platelets to clump together as part of a blood clot. Clopidogrel (Noklot (300 mg)) is prescribed ...

Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Clopidogrel Tablets USP 75mg, which is being launched. Clopidogrel Tablets USP ...

A single lot of 75-mg clopidogrel tablets that was distributed nationwide is being recalled by the manufacturer due to mislabeling. International Laboratories, LLC voluntarily initiated the recall ...

Golden State Medical Supply, Inc. has voluntarily recalled 1 lot of Clopidogrel 75mg Tablets and 1 lot of Atenolol 25mg Tablets due to a report stating that a bottle containing Clopidogrel 75mg ...

October 1, 2007 (Bridgewater/Princeton, NJ)-The US FDA has approved a new 300-mg tablet of clopidogrel (Plavix, Sanofi-aventis/Bristol-Myers Squibb) for use as a ...

Diminished antiplatelet effect in patients with two loss-of-function alleles of the CYP2C19 gene. Increased risk of bleeding. Premature discontinuation increases risk of cardiovascular events; if ...

-- A New Step Forward May Help Increase Appropriate Early Use of Plavix(R) by Simplifying Administration in Acute Coronary Syndrome Patients Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and ...

Bridgewater/Princeton, NJ-The US FDA has approved a new 300-mg tablet of clopidogrel (Plavix, Sanofi-Aventis/Bristol-Myers Squibb) for use as a loading dose in acute ...